{
  "schema": "pestle.medicine.v1",
  "url": "https://pestle.health/uk/memantine",
  "country": "GB",
  "medicine": "Memantine",
  "activeIngredient": "Memantine hydrochloride",
  "source": {
    "type": "Patient information leaflet approved by the UK medicines regulator (MHRA)",
    "product": "Memantine Hydrochloride 10 mg Film-Coated Tablets.",
    "licenceNumber": "PL 17907/0290",
    "url": "https://mhraproducts4853.blob.core.windows.net/docs/95f0585c2b1e193a1d5122a594c8a8dbc5df72a8",
    "leafletDate": "2026-10-16"
  },
  "checkedAgainstSource": "2026-11-19",
  "automatedCheck": {
    "sideEffectsListed": 24,
    "wordingFoundInLeaflet": 22,
    "notFound": 2
  },
  "reviewedBy": null,
  "whatItIsFor": "Memantine is an anti-dementia medicine used to treat people with moderate to severe Alzheimer's disease. It acts on NMDA-receptors in the brain to improve the transmission of nerve signals and the memory.",
  "keyFacts": [
    "The usual adult and elderly dose is 20 mg once a day, reached gradually over the first 4 weeks.",
    "Take it regularly every day at the same time of day, with or without food.",
    "Tell your doctor if you have a history of epileptic seizures, a recent heart attack, heart failure, uncontrolled high blood pressure or kidney problems.",
    "It is not recommended for children and adolescents under 18 years.",
    "The use of memantine in pregnant women is not recommended and women taking it should not breast-feed."
  ],
  "doNotTake": [
    "If you are allergic to memantine or any of the other ingredients of this medicine"
  ],
  "checkWithDoctorFirst": [
    "History of epileptic seizures",
    "Recent heart attack (myocardial infarction), congestive heart failure or uncontrolled high blood pressure (treatment should be carefully supervised and the benefit reassessed regularly by your doctor)",
    "Kidney problems (renal impairment): your doctor should closely monitor kidney function and adjust the dose if necessary",
    "Use at the same time as amantadine, ketamine, dextromethorphan and other NMDA antagonists should be avoided",
    "Not recommended for children and adolescents under 18 years"
  ],
  "seriousSideEffects": [],
  "sideEffectsByFrequency": [
    {
      "frequency": "Common",
      "meaning": "Up to 1 in 10 people",
      "effects": [
        "Headache",
        "Sleepiness",
        "Constipation",
        "Elevated liver function tests",
        "Dizziness",
        "Balance disorders",
        "Shortness of breath",
        "High blood pressure",
        "Drug hypersensitivity"
      ]
    },
    {
      "frequency": "Uncommon",
      "meaning": "Up to 1 in 100 people",
      "effects": [
        "Tiredness",
        "Fungal infections",
        "Confusion",
        "Hallucinations",
        "Vomiting",
        "Abnormal gait",
        "Heart failure",
        "Venous blood clotting (thrombosis/thromboembolism)"
      ]
    },
    {
      "frequency": "Very rare",
      "meaning": "Up to 1 in 10,000 people",
      "effects": [
        "Seizures"
      ]
    },
    {
      "frequency": "Not known",
      "meaning": "The leaflet says how often is not known",
      "effects": [
        "Inflammation of the pancreas",
        "Inflammation of the liver (hepatitis)",
        "Psychotic reactions",
        "Depression (Alzheimer's disease has been associated with this, and it has been reported in patients treated with memantine)",
        "Suicidal ideation (Alzheimer's disease has been associated with this, and it has been reported in patients treated with memantine)",
        "Suicide (Alzheimer's disease has been associated with this, and it has been reported in patients treated with memantine)"
      ]
    }
  ],
  "otherMedicinesTheLeafletMentions": [
    "Amantadine, ketamine, dextromethorphan",
    "Dantrolene, baclofen",
    "Cimetidine, ranitidine, procainamide, quinidine, quinine, nicotine",
    "Hydrochlorothiazide (or any combination with hydrochlorothiazide)",
    "Anticholinergics (generally used to treat movement disorders or intestinal cramps)",
    "Anticonvulsants (used to prevent and relieve seizures)",
    "Barbiturates (generally used to induce sleep)",
    "Dopaminergic agonists (such as L-dopa, bromocriptine)",
    "Neuroleptics (used in the treatment of mental disorders)",
    "Oral anticoagulants",
    "Any other medicines, including medicines obtained without a prescription"
  ],
  "pregnancyAndBreastfeeding": "The use of memantine in pregnant women is not recommended, and women taking memantine should not breast-feed. If you are pregnant, breast-feeding, think you may be pregnant or are planning a baby, ask your doctor or pharmacist for advice before taking it.",
  "howToTake": [
    "The recommended dose for adults and elderly patients is 20 mg once a day, built up gradually: week 1 half a 10 mg tablet, week 2 one 10 mg tablet, week 3 one and a half 10 mg tablets, week 4 and beyond two 10 mg tablets once a day.",
    "Swallow the tablets with some water, once a day at the same time each day, with or without food. The 10 mg tablet can be divided into equal doses.",
    "If you have kidney problems, your doctor will decide on a dose that suits you and will monitor your kidney function.",
    "Continue for as long as it is of benefit to you; your doctor should assess your treatment regularly.",
    "If you forget a dose, wait and take the next dose at the usual time. Do not take a double dose."
  ],
  "notice": "Reference information taken from the official leaflet. Not medical advice. Other makers of the same medicine may publish slightly different leaflets."
}